|
|
Clinical application of Dydrogesterone in ovulation induction under high progesterone condition |
HUANG Yun LIAO Hua YUE Lin-lin |
Department of Reproductive Medicine,Ganzhou Maternal and Child Health Hospital,Jiangxi Province,Ganzhou 341000,China |
|
|
Abstract ObjectiveTo investigate the application effect of Dydrogesterone in the treatment of infertility patients due to hypofunction of ovarian reserve in the regimen of ovulation induction.MethodsFrom January 2016 to February 2017,213 cases of infertility patients due to hypofunction of ovarian reserve in our hospital were selected as research objects.According to the admission time,they were divided into group A and group B.The patients in group A were treated by Dydrogesterone combined with injection of urofollitropin for ovulation (n=144),the patients in group B were implemented antagonist regimen(n=69).The difference of therapeutic effect in the two groups was analyzed.ResultsDuring ovulation induction,no one was presented with LH peak.The number of ova,number of mature ova,number of fertilization,number of cleavage,rate of ovum-plantation,rate of mature ova,rate of fertilization,rate of cleavage,and rate of high quality embryos in the two groups were compared,and the differences were not statistically significant(P>0.05).The embryo resuscitation success rate,embryo implantation rate and biochemical pregnancy rate of two groups in PET period were compared,and the differences were not statistically significant(P>0.05).The clinical pregnancy rate in group A was higher than that in group B,the difference was statistically significant(P<0.05).ConclusionIn the process of ovulation,high progesterone status created by Dydrogesterone for ovulaton induction can effective inhibit the LH peak.What′s more,the clinical pregnancy rate in Dydrogesterone combined group is higher than that in the antagonist group,and is favorable regimen for ovulation induction.
|
|
|
|
|
[2] |
叶静,陈秋菊,匡延平.卵巢功能正常患者高孕激素状态下促排卵的内分泌特征及IVF/ICSI临床结局的研究[J].生殖与避孕,2015,35(6):393-400.
|
[4] |
沈铿,马丁.妇产科学[M].北京:人民卫生出版社,2015.
|
[5] |
刘尧芳,廖运梅,王芳,等.卵巢低反应患者高孕激素状态下促排卵的有效性研究[J].现代妇产科进展,2016,25(11):846-848.
|
[6] |
迟洪滨,辛玲丽,李蓉,等.地屈孕酮、琪宁及安琪坦黄体支持方案对宫腔内人工授精妊娠结局的影响[J].中华医学杂志,2016,96(23):1830-1833.
|
[7] |
叶红娟,陈秋菊,匡延平.多囊卵巢综合征患者在高孕激素超促排卵中LH与IVF/ICSI临床结局的相关性分析[J].生殖与避孕,2016,36(3):177-184.
|
[1] |
Zhang J,Qiu X,Gui Y,et al.Dehydroepiandrosterone improves the ovarian reserve of women with diminished ovarian reserveand is a potential regulator of the immune response in the ovaries[J].Biosoi Trends,2015,9(6):350-359.
|
[3] |
Kuang YP,Chen QJ,Fu YL,et al.Medroxyprogesterone acetate is an effective oral alternative for prevent ing premature luteinizing hormone surgesinwomen undergoing controlled ovarian hyperstimulation for in vitro fertilization[J].Fert Steril,2015,104(1):62-70.
|
[8] |
李芝.氯米芬在控制性超促排卵过程中抑制早发LH峰作用的观察[D].石家庄:河北医科大学,2016.
|
[9] |
方玉,陈红,陈洁瑛,等.氯米芬联合HMG在促排卵人工授精周期中防止过早内源性黄体生成素峰的有效性研究[J].现代妇产科进展,2016,25(4):277-280.
|
[10] |
匡蕾.黄体酮联合地屈孕酮治疗先兆流产的效果分析[J].中国当代医药,2015,22(1):86-88.
|
[11] |
郭涓.安胎丸联合地屈孕酮片治疗不明原因复发性流产的临床效果[J].中国当代医药,2015,22(35):85-87.
|
[12] |
刘亚丽,于莎,陈秋菊,等.克罗米芬联合高孕激素促排卵抑制早发LH峰的临床结局研究[J].生殖与避孕,2016,36(4):263-269.
|
[13] |
朱秀娴,陈秋菊,匡延平.卵巢功能正常患者使用不同促性腺激素联合安宫黄体酮促排卵的IVF/ICSI-FET结局[J].生殖与避孕,2015,35(5):310-317.
|
[14] |
项云改,宋玉霞,李艳,等.不同黄体支持方案对体外受精-胚胎移植结局的影响[J].中国妇幼保健,2015,30(15):2390-2392.
|
[15] |
李元,罗克莉,龚斐.地屈孕酮预处理可以增加拮抗剂方案中卵泡均匀性[J].生殖医学杂志,2013,22(10):806-810.
|
|
|
|